Innovation events and
open innovation conferences

Find out top innovation events and conferences worldwide.
Find unique discounts and experts attending innovation events.

Thought-provoking content created and delivered by innovation experts. In one jam-packed day you’ll hear about:

✔️ Driving business innovation during a global pandemic

✔️ Accelerating Innovation and Impact at Scale

✔️ Fielding High-performing Innovation Teams

✔️ Investing in Innovation

✔️ Creating a Culture of Internal, Intentional Disruption

✔️ AI Driven Innovation

The best of the best, all within the click of a button.

We’re bringing together innovation leaders from the worlds largest companies and the world’s most exciting start-ups to share their expertise. How are billion dollar companies reacting to the crisis? And how are those who were seeking scale in 2020 managing their growth and ambitions?

Sit back. Hit play. Learn lots. Repeat.

Innovation at scale? Human-centered design? Budgeting for innovation? Got it all. With 10+ experts over you’re guaranteed to walk away with tons of new and proven tactics, strategies, and ideas to ensure business agility and profitability.

Unrivaled expertise, all delivered virtually.

Our mission is to help you reinvigorate your business with fresh ideas, discover how to deliver breakthrough results, and manage success as the world emerges from an unprecedented crisis.

WHAT IS BIOTECH WEEK BOSTON?


Biotech Week Boston is dedicated to accelerating the business of biotechnology through new ideas, science, technology and partnerships to make a positive impact on patient health. 

You’ll find thought-leaders and potential partners from discovery, financing, manufacturing, clinical trials, who can help drive you closer to success. It’s an unparalleled opportunity to meet and do business with those who are shaping our industry's future, from researchers and investors, to CEOs and founders.

Add a dazzling awards party, and an evening of rock and roll, Biotech Week Boston is also the convergence of business and fun.

Vonlanthen Group of Companies is thrilled to be presenting the 4th Open Innovation Summit in Berlin, on November 18th and 19th, 2020.

This Summit will continue its tradition of providing a cross-functional platform for open innovation leaders to come together and to exchange their practical experiences in adoption of open innovation, applying open innovation to create competitive products, services and processes, to enable novel business models and to network with the key stakeholders.

Join us as we continue exploring the technical and business solutions, and lessons learned in the ongoing debate of open innovation. See you in November 2020!

 

Who Should Attend

Chief Executives, Directors, Vice Presidents, Department Heads, Leaders and Managers specialising in: Business Planning Corporate Development Innovation Excellence Investments/Startups Operations Management Portfolio Management Project Controlling Quality Management R&D Business R&D Cooperation Strategic Marketing Business Development Financial Planning Innovation Management Knowledge Management Performance Measurement Product Development Project Management Research & Development R&D Controlling R&D Technology Innovation

 

Key Practical Learning Points of the Summit

Improving idea sourcing, quality, processes, performanceAdopting new tech and tools to mature creation of competitive advantages through open innovationEmpowering developability and deliverability of open innovation solutionsDefining metrics to measure open innovation impactDesigning open innovation platforms from concept to implementation to enable OI ecosystemApplying emerging OI approaches to create novel business models for product, process and servicesEstablishing partnership with internal and external OI communities, and learning from failuresEnhancing intellectual property (IP) strategy to enable and protect innovations

Upcoming innovation events 2020 | Filter: Informa Connect

YOUR OPPORTUNITY TO ENGAGE WITH GLOBAL LIFE SCIENCE PARTNERS

BioPharm America attracts a wide range of business leaders, including senior executives of leading biotech companies, business development teams from large and midsize pharmaceutical companies, investors and other industry experts.

 

SPONSORSHIP OPPORTUNITIES

Leverage custom opportunities to engage attendees in-person and through digital campaigns. Whether you want to reinforce your thought leadership, build your brand, generate leads, or shake hands with new partners – we have you covered!

BREAKING DOWN THE COMPLEXITY

New regulations, fast changing case law, constant consultations and reviews - it's no wonder the pharmaceutical industry is seen as one of the toughest places to practice law. 

The Pharma Law Academy has been designed to cut through the complexity, delivering you all the information and skills needed to ensure your success, whether you are an in-house lawyer or practicing in a legal firm.

Clinical and Early Stage CAR T Cell and Gene Therapy Advances
  • Push the boundaries of CD19 with solid tumours, combination therapies and safety switches
  • Transition technologies from bench to bedside: CRISPR, Exosomes and more..
  • Understand how to build a sustainable process early on for optimum clinical translation
Cell and Gene Therapy Bioprocessing
  • Build a strategy for monitoring quality across your process with PAT and automated analytics
  • Get to grips with technologies and novel platforms for efficient upstream and downstream processes
  • Simplify manufacturing automation and prepare for commercialization
Cell & Gene Therapy Commercialization
  • Work towards industry 4.0 – integrating manufacturing and delivery into healthcare
  • Optimise the way you work with external partners to drive commercialization
  • Ensure profitability with forward thinking in facility design and scalability strategies
Supply Chain Barriers: Upstream and Downstream Considerations
  • Improve confidence in your raw material supply chain – vectors, risk mitigation and more
  • Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing
  • Prepare for successful delivery to patients & supply chain scale up
Cell and Gene Therapy Connect – Partnering Track
  • Keep abreast of the evolving landscape of cell and gene therapies
  • Tackle collaboration – new outsourcing models, when to make the decision to ‘spin out’ and more
  • Dive into pharmacoeconomic approaches to reimbursement
Bio fabrication – The Path to Commercialization: With ARMI
  •  Benefit from peer experience with automated manufacturing for Tissue Engineered Medical Products (TEMPs)
  • Reduce COGS with modular processes & tools for manufacturing TEMPs at scale
  • Be a part of the burgeoning supply chain for Tissue Engineered Medical Products industry

Cell and Gene Therapy Conference

21 - 24 September, 2020

Boston, United States

Clinical and Early Stage CAR T Cell and Gene Therapy Advances Push the boundaries of CD19 with solid tumours, combination therapies and safety switches Transition technologies from bench to bedside: CRISPR, Exosomes and more.. Understand how to build a sustainable process early on for optimum clinical translation Cell and Gene Therapy Bioprocessing Build a strategy for monitoring quality across your process with PAT and automated analytics Get to grips with technologies and novel platforms for efficient upstream and downstream processes Simplify manufacturing automation and prepare for commercialization Cell & Gene Therapy Commercialization Work towards industry 4.0 – integrating manufacturing and delivery into healthcare Optimise the way you work with external partners to drive commercialization Ensure profitability with forward thinking in facility design and scalability strategies Supply Chain Barriers: Upstream and Downstream Considerations Improve confidence in your raw material supply chain – vectors, risk mitigation and more Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing Prepare for successful delivery to patients & supply chain scale up Cell and Gene Therapy Connect – Partnering Track Keep abreast of the evolving landscape of cell and gene therapies Tackle collaboration – new outsourcing models, when to make the decision to ‘spin out’ and more Dive into pharmacoeconomic approaches to reimbursement Bio fabrication – The Path to Commercialization: With ARMI  Benefit from peer experience with automated manufacturing for Tissue Engineered Medical Products (TEMPs) Reduce COGS with modular processes & tools for manufacturing TEMPs at scale Be a part of the burgeoning supply chain for Tissue Engineered Medical Products industry

HARNESS THE THERAPEUTIC POWER OF THE HUMAN MICROBIOME

Explore The Science Of The Human Microbiome & Utilize Emerging Technologies
  • What is the future of microbiome therapeutics?
  • Uncover best practice strategies for designing R&D programs
  • Adapt emerging technologies and applications. Find the right platforms to provide the data you need.
  • Going beyond the gut: Apply existing knowledge to new therapeutic areas
  • Standardized analysis: The shift towards sequencing
Microbiome Mechanisms of Action: Manufacturing And Commercialization Challenges
  • Address end-to-end manufacturing issues
  • Manage the clinical data waiting game  
  • Is working with CROs/CDMOs an option?
  • Meet at the intersection: Commercialization and rigorous research
  • Discover new or hybrid techniques to effectively deliver therapeutics to patients
  • Regulatory challenges: Plan your path to compliance
     
Connect With Microbiome Masters And Beyond...

Biotech Week Boston: Bring Your Partnering A-Game To The Table 

  • Big Pharma investment in the microbiome space: What are they looking for?
  • Microbiome 101 for investors: Long-term strategies to look out for.

partneringONE®
Register and receive access to partneringONE®, our partnering tool that allows you to view the full attendee list and send/receive meeting requests before you arrive. This benefit goes live approximately 4 weeks before the event.

THE LARGEST BIOPROCESSING EVENT BRINGING YOU THE SCIENCE, TECHNOLOGIES AND PARTNERS NEEDED TO ACCELERATE PROMISING BIOLOGICS TOWARDS COMMERCIAL SUCCESS

Connect with 2000+ global scientists, engineers and executives working across the entire spectrum of biopharmaceutical development and production

THE CELL AND GENE THERAPY CONFERENCE FOR GROUND BREAKING BIOPROCESSING, MANUFACTURING & SUPPLY CHAIN STRATEGIES

World renowned leaders share the latest technologies & commercialization techniques to revolutionize your cell, gene and CAR-T clinical and late stage programs

CONNECT WITH LEADERS WHO ARE READY TO TALK ABOUT DIVERSITY AND INCLUSION WITH PRACTICAL SOLUTIONS FOR PROPELLING ALL DIMENSIONS OF DIVERSITY THROUGHOUT YOUR ORGANIZATION

TOGETHER WE CAN MAKE A DIFFERENCE

LEVERAGE INSIGHT FROM REAL-LIFE BD EXPERIENCES AS YOU ANALYZE THE MOST RELEVANT DEALS IN BIOTECH

An invitation-only, off-the-record forum that brings together senior-level biopharma executives to network and share insights on the business challenges and opportunities impacting the industry. Proudly part of Biotech Week Boston.

DISCOVER THE VALUE OF MENTORSHIP


Our Boston BD kick-off panel focused on the true meaning of mentorship and how it can empower executives to achieve success when stepping into the boardroom. 

Our latest video features the following senior-level executives' mentorship perspectives.

  • Thomas de Vlaam, CEO and Founder, Amylon Therapeutics
  • Laurie Glimcher, M.D., President and CEO, Dana-Farber Cancer Institute
  • Andy Plump, M.D., Ph.D., President R&D, Takeda
  • Paula Soteropoulos, President and CEO, Akcea Therapeutics
  • Edward Kaye, M.D., CEO, Stoke Therapeutics

MPROVE EFFICIENCY ACROSS ALL PHASES OF BIOMANUFACTURING

The BioProduction agenda features 5 concurrent streams of content covering the entire spectrum of biopharmaceutical development and production.  Your main conference pass allows you to attend any sessions across all 5 streams, providing you with a customisable learning experience.

Upstream Processing & Cell Culture

Optimise speed, titres and quality through process intensification, media development, real time monitoring, application of machine learning and process modelling.

Manufacturing Strategy, Technology and Smart Factories

Apply digital technologies, AI, and machine learning to create smarter and more flexible facilities.

Downstream Processing

Utilise novel approaches and technologies to enable efficient next generation downstream processes.

Microbial Manufacturing

Adapt manufacturing strategies for next generation biologics through the application of yeast and E. coli expression systems.

Bioanalytical & Formulation

Enhance bioanalytical development and achieve a high quality product using optimal analytical strategies and formulation whilst reducing timelines.

MEET DIRECTLY WITH THE FDA AND REGULATORY SPEAKERS

Each year, this meeting brings in 5+ FDA speaker's from CBER/CDER that are onsite with a big presence. They’ll be able to answer all of your regulatory questions and present on some key topic areas of interest. We’re finalizing the representatives that are coming. In the meantime, here are some potential topic areas that will be addressed:

Most Problematic Areas of Submissions for Analytical Characterization and Bioassay Development
Regulatory Updates and Insights on Emerging Technologies for Analytical and Bioassay Development
Regulatory Guidelines on Analytical Procedure Validation vs. Qualification
FDA Town Hall - Open Forum Q&A with Multiple FDA Reviewers

CLINICAL TRIALS: ACCELERATE YOUR PATH TO GROUNDBREAKING THERAPEUTIC DEVELOPMENT

Thank you to everyone who attended Clinical Trials Europe 2019! Mark your calendar for next year's meeting on 2 - 4 November 2020.

Elevate your partnerships, outsourcing, operations and technology strategies with leading insights and collaboration

IMPROVE CHARACTERISATION ACROSS ALL PHASES OF BIOLOGICS DEVELOPMENT AND PRODUCTION

For 2019, the Bioanalytical and Formulation Summit will run as a 3-day stream as part of BioProduction, part of CPhI worldwide.  Key topics covered as part of the Bioanalytical stream are listed below.

Bioanalytical Method Development, Validation, and Transfer
  • Explore industry approaches to analytical strategies
  • Create more efficient workflows by completing a much as possible earlier in development
  • Refine analytical method validation and qualification
Protein Characterisation
  • Understand Critical Quality Attributes and Post Translational Modifications and how to measure them
  • Develop methods for analysing novel biologic formats
  • Apply new technologies and orthogonal methods to protein characterisation
Bioassay
  • Accelerate bioassay timelines by applying phase appropriate potency assay strategies
  • Improve product quality by analysing impurities and testing immunogenicity
  • Gain insight into bioassay approaches for complex cell therapies
Formulation and Stability Testing for Biopharmaceuticals
  • Latest advances and techniques in predicting the stability of biologics
  • Learn to balance dosage and potency for formulation development
  • Discuss the relationship between formulation, immunogenicity and impurities when producing biologics

CONNECT WITH KEY BUYERS AT TIDES EUROPE 2020 IN VIENNA


Whether you're increasing your company profile, launching a new product or creating business development opportunities, we have flexible and tailored solutions that will optimize your investment.

Clinical and Early Stage CAR T Cell and Gene Therapy Advances
  • Push the boundaries of CD19 with solid tumours, combination therapies and safety switches
  • Transition technologies from bench to bedside: CRISPR, Exosomes and more..
  • Understand how to build a sustainable process early on for optimum clinical translation
Cell and Gene Therapy Bioprocessing
  • Build a strategy for monitoring quality across your process with PAT and automated analytics
  • Get to grips with technologies and novel platforms for efficient upstream and downstream processes
  • Simplify manufacturing automation and prepare for commercialization
Cell and Gene Therapy Commercialization
  • Work towards CART 3.0 with off the shelf technology platforms and novel CARs
  • Optimise your strategy to deliver an economically viable manufacturing journey
  • Ensure profitability with forward thinking in facility design and scalability strategies
Supply Chain Barriers: Upstream and Downstream Considerations
  • Improve confidence in your raw material supply chain – vectors, risk mitigation and more
  • Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing
  • Prepare for successful delivery to patients & supply chain scale up
Cell and Gene Therapy Connect – Partnering Track
  • Keep abreast of the evolving landscape of cell and gene therapies
  • Tackle collaboration – new outsourcing models, when to make the decision to ‘spin out’ and more
  • Dive into pharmacoeconomic approaches to reimbursement
Pre-conference focus sessions

With our expert trainer and speaker Christopher Bravery we are putting together 2 half day regulatory sessions focussing on key topics which will allow for commercial success. 

We start with preparing for submission with a specific focus on Module 3. Following that put your new found knowledge to work in our session diving into lessons learnt from the 22 ATMPs submitted to the EMA. Stay tuned for more information….

Cell Therapy Manufacturing & Gene Therapy Congress

01 - 04 December, 2020

Amsterdam, Netherlands

Clinical and Early Stage CAR T Cell and Gene Therapy Advances Push the boundaries of CD19 with solid tumours, combination therapies and safety switches Transition technologies from bench to bedside: CRISPR, Exosomes and more.. Understand how to build a sustainable process early on for optimum clinical translation Cell and Gene Therapy Bioprocessing Build a strategy for monitoring quality across your process with PAT and automated analytics Get to grips with technologies and novel platforms for efficient upstream and downstream processes Simplify manufacturing automation and prepare for commercialization Cell and Gene Therapy Commercialization Work towards CART 3.0 with off the shelf technology platforms and novel CARs Optimise your strategy to deliver an economically viable manufacturing journey Ensure profitability with forward thinking in facility design and scalability strategies Supply Chain Barriers: Upstream and Downstream Considerations Improve confidence in your raw material supply chain – vectors, risk mitigation and more Stay up to date on cryo considerations when moving from clinical to commercial phase manufacturing Prepare for successful delivery to patients & supply chain scale up Cell and Gene Therapy Connect – Partnering Track Keep abreast of the evolving landscape of cell and gene therapies Tackle collaboration – new outsourcing models, when to make the decision to ‘spin out’ and more Dive into pharmacoeconomic approaches to reimbursement Pre-conference focus sessions With our expert trainer and speaker Christopher Bravery we are putting together 2 half day regulatory sessions focussing on key topics which will allow for commercial success.  We start with preparing for submission with a specific focus on Module 3. Following that put your new found knowledge to work in our session diving into lessons learnt from the 22 ATMPs submitted to the EMA. Stay tuned for more information….

New Half-Day Sessions
  • Tumor-conditional Immunotherapy
  • Tissue Specific Delivery of Antibodies
  • Reverse Translation: Antibody Engineering and Clinical Data
  • Bioinformatics and Computational Tools for Antibody Optimization and Engineering
  • Emerging Technologies and Approaches for Antibody Engineering
  • Systems Immunology for Therapeutic Target Discovery
  • Targeting Subcellular Trafficking Pathways to Generate Antibody Therapeutics
  • Special Joint Session with the Chinese Antibody Society
New Half-Day Workshops
  • Bispecific Antibodies: New Strategies and Case Studies
  • Machine Learning in Antibody and Protein Engineering
Expanded

Conference Advisory Board and Guest Session Chairs

Reach a global audience of 100,000+. Share your event.

Past innovation events 2020 | Filter: Informa Connect

Patient and Caregiver Perspectives –
Explore New Developments in Cures, Community, Collaboration and the Care Continuum for Patients and Caregivers

Science Luminaries 
Advancements in Gene Therapy that Are Tearing Down Barriers to Discovery in Rare Disease

Regulatory and Policy Update Address –
Legislative Updates and New Initiatives within the FDA’s Orphan Drug Program

Focus on Funding –
The Impact of Disruptive Investors, Drivers of Value and Funding Models for Success

Technology Spotlight 
Artificial Intelligence (AI) and Advanced Data Analytics — Reshaping Complex Diagnostics and Decision-Making in Rare Disease Drug Development

CAR AND T CELL THERAPIES: PIONEERING POINT OF CARE WITH INNOVATIVE MANUFACTURING AND COMMERCIALIZATION STRATEGIES

Revolutionizing cell engineering - ground breaking autologous and allogeneic treatments for blood borne and solid tumors

COURSE OVERVIEW

Protect patients and protect yourselves by attending this two-day course ensuring that you fully understand how to safeguard your biologic from viral contamination! With the rapid growth and dependency on the biological drug market, now is the time to ensure that you are employing the best analytical and clearance techniques to guarantee safety. Over two days you will explore in an interactive environment the sources of viral contamination, regulatory expectations, techniques to assess viral clearance and ways to mitigate risks and changes.

WHAT TO EXPECT

Critical Regulatory Updates and Effective Strategies for Monitoring & Oversight
  • Gain Insights from Government Perspectives on High-Priority Risks
  • Safeguard Transparency with Charitable Organizations
  • Revamp Your Compliance Program with Leading Strategies to Mitigate Risks
  • Compliant Frameworks for Nurse Educator Programs and Field Team Design
Novel Approaches to Services, Program Architecture and Operational Management
  • Measuring the Success of Patient Support Programs — Explore KPI’s, Data Visualization and Road Mapping
  • Navigate Innovation, AI, Changing Distribution Models and Market Mergers
  • Strengthen Overall Program Architecture — Explore Program Models and Sourcing Structure
Unparalleled Knowledge and Information exchange
  • Re-Imagine Patient Services — Trends to Watch
  • Benefit for Industry Level Setting and Benchmarking
  • Leverage Internal and External Relationships for Program Success
New Half-Day Workshops!

Attend the pre-conference workshops for a ‘road map’ to finding the right antibody for therapeutic development including discussion on choosing the right target and format, biology, IP, clinical and commercial considerations, and avoiding liabilities.

  • Morning - Finding the Right Antibody
  • Afternoon - The “Nuts and Bolts” of Antibodies
Brand New Session Themes with All New Speakers, Data and Case Studies
  • Potentiating Antibodies through Conjugation
  • Bispecific Formats for T Cell Activation
  • Cell Engagers for the Innate Immune System
  • Advances in Computational and Machine Learning Approaches for Antibody Engineering
  • Antibody Discovery and Developability
  • Modifying Fc Interactions to Enhance Antibody Therapies

 

 

Networking Opportunities!

Networking App - All registered attendees receive access to our conference networking app, which allows you to view the full attendee list and schedule meetings before you arrive in Amsterdam

Networking Cocktail Reception - Located inside the exhibit hall, attendees can enjoy cocktails while viewing scientific posters, live exhibitor demonstrations, and exchange business cards with fellow attendees. 

WHAT TO EXPECT

Advancing Risk Management Models
  • Examine new models for managing compliance risk for patient engagement
  • Preparation and training for internal audits — Understand internal business ethics and compliance
  • Managing risk with third party vendors 
  • Discuss industry trends in automating compliance monitoring activities to address compliance risk
Understand How Evolving Regulatory Guidance and Trends Impact Your Compliance Program
  • Review of IMC codes and updates, Lama Abi Khaled, Executive Director, Ethics, Legal & RegulatoryInnovative Medicines Canada
  • Health Canada Updates and Q&A, Alain G. Musende, PhD, Manager, Therapeutic Effectiveness and Policy BureauHealth Canada [invited]
  • Q&A Session with Patrick Massad, Commissioner, Pharmaceutical Advertising Advisory Board (PAAB)
  • DOJ Guidance on Ensuring Effective Compliance Programs: Latest Updates and Recent Development, Nicholas Connor, Senior Counsel, Government Investigations & LitigationJohnson & Johnson
Examine Best Practices in Data Privacy, IP Law and Competition and Employment Law

Dedicated Content Track for In-house Legal Counsel addressing:

  • The risks associated with data breaches and how to manage them
  • Data privacy with third-party suppliers
  • Complying with new data privacy regulations announced in Canada November 2018
  • Best practices in IP Law —
    Copyright, Trademark and Patent
  • Ensuring compliance with CASL
  • Competition and Employment Law —
    Ethical approaches and pitfalls to avoid

PCC Canada

03 June, 2020 - 03 June, 2020

Montreal, Canada

WHAT TO EXPECT Advancing Risk Management Models Examine new models for managing compliance risk for patient engagement Preparation and training for internal audits — Understand internal business ethics and compliance Managing risk with third party vendors  Discuss industry trends in automating compliance monitoring activities to address compliance risk Understand How Evolving Regulatory Guidance and Trends Impact Your Compliance Program Review of IMC codes and updates, Lama Abi Khaled, Executive Director, Ethics, Legal & Regulatory, Innovative Medicines Canada Health Canada Updates and Q&A, Alain G. Musende, PhD, Manager, Therapeutic Effectiveness and Policy Bureau, Health Canada [invited] Q&A Session with Patrick Massad, Commissioner, Pharmaceutical Advertising Advisory Board (PAAB) DOJ Guidance on Ensuring Effective Compliance Programs: Latest Updates and Recent Development, Nicholas Connor, Senior Counsel, Government Investigations & Litigation, Johnson & Johnson Examine Best Practices in Data Privacy, IP Law and Competition and Employment Law Dedicated Content Track for In-house Legal Counsel addressing: The risks associated with data breaches and how to manage them Data privacy with third-party suppliers Complying with new data privacy regulations announced in Canada November 2018 Best practices in IP Law — Copyright, Trademark and Patent Ensuring compliance with CASL Competition and Employment Law — Ethical approaches and pitfalls to avoid

PROPEL DISCLOSURE, PUBLICATION AND MEDICAL COMMUNICATION SUCCESS

Proven strategies to ensure clinical trial data is on the pulse of global regulatory requirements, reported accurately, redacted appropriately and achieves meaningful patient engagement from study start up through post market publications.

DRIVE INNOVATION TO IMPROVE CARE, OUTCOMES AND VALUE

Network with state officials, Medicaid directors, health plans and pharmaceutical executives to hear policy updates and discuss approaches to care management, social determinants of health, alternative payment models and member engagement strategies.

STAY AT THE FOREFRONT OF BIOTECH INNOVATION BY TAPPING INTO THE RICHEST POOL OF FINANCE, EXPERIENCE, AND TALENT

An invitation-only, off-the-record forum that brings together the past, present and future leaders in the biopharma community to network and share insights into the industry's challenges and opportunities.

EUROPE’S LEADING PHARMACEUTICAL LAW NETWORKING AND KNOWLEDGE HUB

Make New Contacts, Meet Authority Experts and Discuss the Latest Legal Developments

Insights. Networking. Interactive Discussions.

CROSS-FERTILIZE IDEAS AND BEST PRACTICES WITH RESEARCHERS FROM DIFFERENT DISCIPLINES

The TIDES 2020 agenda format features 6 scientific tracks covering in-depth development strategies, trends and technologies across the entire oligonucleotide and peptide spectrum. In addition, we have 1 partnering track that will keep you ahead of your competition, and work towards collaborations. Your main conference pass includes access to all 7 tracks, allowing your team to create a customized agenda tailored to your company's current challenges.

One-to-one meetings

Access hundreds of potential partners with the world's leading web-based partnering system, partneringONE®.

 

Pitch your company

Presenting at ChinaBio® Partnering Forum is the most direct way to get your innovative asset or idea directly in front of real decision makers.

 

Gain insight

Hear key biotech and pharma leaders discuss the latest industry trends in workshops and panels.

 

Showcase your brand

Sponsor or Exhibit to position your company among the innovators of the life science industry.

 

Informal networking

High caliber networking in an intimate setting.

 

WHAT TO EXPECT

Enforcement and Oversight

Gary Cantrell, Deputy Inspector General for Investigations, Office of Inspector General (OIG), Department of Health and Human Services (HHS)

Craig Carpenito, U.S. Attorney, U.S. Attorney’s Office for the District of New Jersey

Rachael Honig, First Assistant U.S. Attorney, U.S. Attorney’s Office for the District of New Jersey

Amanda Masselam Strachan, Chief, Health Care Fraud Unit, U.S. Attorney’s Office for the District of Massachusetts

Gregg Shapiro, Assistant U.S. Attorney, U.S Attorney’s Office for the District of Massachusetts

Jason Swergold, Co-Chief, Narcotics Unit, U.S. Attorney’s Office for the Southern District of New York

Robert Dodge, Assistant Director, FCPA Unit, U.S. Securities and Exchange Commission (SEC)

Gustav Eyler, Director, Consumer Protection Branch, U.S. Department of Justice (DOJ)

Leadership and Innovation

John Crowley, Chairman of the Board, Chief Executive Officer, Amicus Therapeutics

Joshua Marks, Vice President, Chief Ethics and Compliance Officer, Boehringer Ingelheim

Tina Beamon, Vice President, Chief Compliance Officer, Karyopharm Therapeutics, Inc

Bryant Aaron, Vice President, Chief Compliance, Officer, U.S. Country Head, Ethics and Compliance, Novartis Pharmaceuticals Corporation

Jill Fallows Macaluso, Corporate Vice President, North America, Chief Ethics, Compliance and Privacy Officer, Novo Nordisk

Indrani Lall Franchini, Executive Vice President and Chief Compliance Officer, Alexion Pharmaceuticals, Inc.

Jim Flaherty, Vice President, Associate General Counsel, Rhythm Pharmaceuticals

Kelly Payne, Vice President, Global Ethics and Compliance Officer, Eli Lilly and Company

Jeffrey Levitt, Vice President, Head of Legal Affairs and Compliance, Stemline

Best Practices and Frameworks
  • Spotlight on Digital Health Initiatives Across the Value Chain Transforming the Life Sciences Sector
  • Compliant Patient Interactions from Clinical to Commercial
  • Commercial and Government Pricing Transparency and Reporting
  • Legal Watch-Outs for Partnering and Deal-Making
  • Strategies for Field Team Compliance
  • Third-Party Risk Assessment and Oversight
  • Hub and Specialty Pharmacy Contract Oversight and Risk Assessment
  • Patient Data and How It Impacts HIPAA, CCPA, GDPR and Overall Organizational Integrity
  • International Trends, Regulations and Best Practices Around the World for Global Compliance
  • Medical Affairs Compliance
  • Product Communication — From Pre-Approval to Post-Approval
  • Clinical Trial Legal and Contracting Considerations and Risk Management Strategies
  • Speaker Programs — Current and Future Trends
  • Spotlight on Auditing, Monitoring and Data Analytics

PCC 2020

29 April, 2020 - 01 May, 2020

Washington, United States

WHAT TO EXPECT Enforcement and Oversight Gary Cantrell, Deputy Inspector General for Investigations, Office of Inspector General (OIG), Department of Health and Human Services (HHS) Craig Carpenito, U.S. Attorney, U.S. Attorney’s Office for the District of New Jersey Rachael Honig, First Assistant U.S. Attorney, U.S. Attorney’s Office for the District of New Jersey Amanda Masselam Strachan, Chief, Health Care Fraud Unit, U.S. Attorney’s Office for the District of Massachusetts Gregg Shapiro, Assistant U.S. Attorney, U.S Attorney’s Office for the District of Massachusetts Jason Swergold, Co-Chief, Narcotics Unit, U.S. Attorney’s Office for the Southern District of New York Robert Dodge, Assistant Director, FCPA Unit, U.S. Securities and Exchange Commission (SEC) Gustav Eyler, Director, Consumer Protection Branch, U.S. Department of Justice (DOJ) Leadership and Innovation John Crowley, Chairman of the Board, Chief Executive Officer, Amicus Therapeutics Joshua Marks, Vice President, Chief Ethics and Compliance Officer, Boehringer Ingelheim Tina Beamon, Vice President, Chief Compliance Officer, Karyopharm Therapeutics, Inc Bryant Aaron, Vice President, Chief Compliance, Officer, U.S. Country Head, Ethics and Compliance, Novartis Pharmaceuticals Corporation Jill Fallows Macaluso, Corporate Vice President, North America, Chief Ethics, Compliance and Privacy Officer, Novo Nordisk Indrani Lall Franchini, Executive Vice President and Chief Compliance Officer, Alexion Pharmaceuticals, Inc. Jim Flaherty, Vice President, Associate General Counsel, Rhythm Pharmaceuticals Kelly Payne, Vice President, Global Ethics and Compliance Officer, Eli Lilly and Company Jeffrey Levitt, Vice President, Head of Legal Affairs and Compliance, Stemline Best Practices and Frameworks Spotlight on Digital Health Initiatives Across the Value Chain Transforming the Life Sciences Sector Compliant Patient Interactions from Clinical to Commercial Commercial and Government Pricing Transparency and Reporting Legal Watch-Outs for Partnering and Deal-Making Strategies for Field Team Compliance Third-Party Risk Assessment and Oversight Hub and Specialty Pharmacy Contract Oversight and Risk Assessment Patient Data and How It Impacts HIPAA, CCPA, GDPR and Overall Organizational Integrity International Trends, Regulations and Best Practices Around the World for Global Compliance Medical Affairs Compliance Product Communication — From Pre-Approval to Post-Approval Clinical Trial Legal and Contracting Considerations and Risk Management Strategies Speaker Programs — Current and Future Trends Spotlight on Auditing, Monitoring and Data Analytics

IMPROVE YIELDS, LOWER COST, MAINTAIN QUALITY, AND CUT DOWN TIME IN YOUR VACCINE MANUFACTURING PROCESS

Access the Science, Technologies and Contacts You Need to Drive Effective Novel Vaccines to Market

WHERE REGULATORY MEETS E-REGULATORY: BRINGING ANSWERS TO THE PHARMACEUTICAL INDUSTRY

Take your strategy to the next level with leading advice from Regulatory Authorities, key stakeholders and global perspectives

The home of RIM, eSubmissions, Global Regulatory Markets and Filing Variations

IMPLEMENT SUCCESSFUL ACCESS PROGRAMMES FOR INVESTIGATIONAL THERAPIES WHILE NAVIGATING COUNTRY-SPECIFIC REGULATIONS AND GATHERING REAL-WORLD DATA

Global considerations for a variety of early access programmes with an emphasis on collaborating with patient advocates and implementing a holistic programme from beginning to end.

COLLABORATION PLAYBOOK FOR ADVANCING ACCESS AND IMPROVING OUTCOMES ACROSS THE CARE CONTINUUM

A showcase of novel case studies and innovative partnership models that deliver enhanced value, manage costs and improve quality.

GET THE SCOOP - MICROBIOME ARTICLES, INTERVIEWS, AND MORE

Microbiome Therapeutics: Going Beyond the Gut - Oral Microbiome

In this whitepaper we look at the therapeutic potential of the oral microbiome; the mouth is home to over 700 species of bacteria and changes to this microbiome can have a distinct impact on oral health.

Microbiome Therapeutics: Going Beyond the Gut - Gut-Brain Axis

In this whitepaper we look at the therapeutic potential of the gut-brain axis, where current preclinical and clinical studies have demonstrated that the brain can impact the gut microbiota through the autonomic nervous system.

Microbiome Therapeutics: Going Beyond the Gut - Skin Microbiome

In this whitepaper we look at the therapeutic potential of the skin microbiome, where companies are developing both cosmetic and therapeutic products which could have an impact on a number of indications, ranging from acne to aging.r

State of the Industry Report

In December 2018, KNect365 Life Sciences conducted one of the largest surveys of its kind with industry professionals around the world. This final report based on 144 responses reveals unique insights into the state of the industry today; the hottest potential opportunities, the biggest challenges and how industry insiders are tackling them.

If you could ask your regulatory authority one question anonymously, what would it be?

In a recent Microbiome Therapeutics State of the Industry Survey conducted by KNect365 Life Sciences, we asked participants to share the regulatory questions weighing on their mind.

Microbiome Therapeutics

23 - 25 March, 2020

Paris, France

GET THE SCOOP - MICROBIOME ARTICLES, INTERVIEWS, AND MORE Microbiome Therapeutics: Going Beyond the Gut - Oral Microbiome In this whitepaper we look at the therapeutic potential of the oral microbiome; the mouth is home to over 700 species of bacteria and changes to this microbiome can have a distinct impact on oral health. Microbiome Therapeutics: Going Beyond the Gut - Gut-Brain Axis In this whitepaper we look at the therapeutic potential of the gut-brain axis, where current preclinical and clinical studies have demonstrated that the brain can impact the gut microbiota through the autonomic nervous system. Microbiome Therapeutics: Going Beyond the Gut - Skin Microbiome In this whitepaper we look at the therapeutic potential of the skin microbiome, where companies are developing both cosmetic and therapeutic products which could have an impact on a number of indications, ranging from acne to aging.r State of the Industry Report In December 2018, KNect365 Life Sciences conducted one of the largest surveys of its kind with industry professionals around the world. This final report based on 144 responses reveals unique insights into the state of the industry today; the hottest potential opportunities, the biggest challenges and how industry insiders are tackling them. If you could ask your regulatory authority one question anonymously, what would it be? In a recent Microbiome Therapeutics State of the Industry Survey conducted by KNect365 Life Sciences, we asked participants to share the regulatory questions weighing on their mind.

STAY AT THE FOREFRONT OF EUROPEAN BIOTECH DEVELOPMENTS IN AN INTIMATE SETTING UNLIKE ANY OTHER

An invitation-only, off-the-record forum that brings together past, present and future leaders to network and share insights on challenges and opportunities impacting the international biopharma industry.

INTERESTED IN SPONSORSHIP OPPORTUNITIES?

Sponsor an upcoming LeadingBiotech event to enhance your visibility and demonstrate your expertise to a highly qualified audience of  c-level decision makers. All programs are custom-built to align with your unique objectives and may include speaking engagement, passes, branding, and more.

This is the ONLY event that explores the intersection of the holistic pharma marketing team and helps you to deliver more effective marketing strategies that deliver impact across your organization.

Join us this March in NYC and hear proven case studies and best practices to enhance cross-enterprise collaboration resulting in new insights, deeper data correlations and overall transitioning from marketing ideas to market-winning strategies.

FOR PHARMA/BIOTECH/DEVICE COMPANIES TO DRIVE FINANCIAL EXCELLENCE, ENSURE COMPLIANCE AND ALIGN ON INDUSTRY ISSUES

Over 600 CFOs, CAOs, Corporate Controllers and their teams gather annually at the world’s largest event to align on standards, advance the business and accelerate innovation. Known as the “must attend event” providing the highest level of life sciences specific CPE learning, unmatched networking and exclusive regulatory insights.

CELL LINE DEVELOPMENT & ENGINEERING US JOINS BPI US WEST

New for 2020, this year’s Cell Line Development & Engineering US meeting is co-located as part of BioProcess International US West, providing you with a unique opportunity to connect and learn from 1000+ global scientists working further down the bioprocessing spectrum across upstream, downstream, analytics and commercial manufacturing. Access to all scientific tracks, as well as the exhibition, is included with your registration.

EMBRACE. ELEVATE. EMPOWER.

EMBRACE Inclusion and Diversity. ELEVATE Meeting Experiences. EMPOWER to Contribute.

The world’s largest and most exceptional life sciences conference delivering strategic and operational meeting excellence. Corporate and third-party planners convene with suppliers and DMC partners to build relationships and engage in an unmatched learning experience.

FROM SCIENTIFIC BREAKTHROUGH TO COMMERCIAL OPPORTUNITY: OVERCOMING THE BUSINESS CHALLENGES OF ONCOLOGY DEVELOPMENT

An invitation-only, off-the-record forum that brings together the past, present and future leaders to network and share expertise in cancer therapeutics.

ROSS-FERTILIZE IDEAS AND BEST PRACTICES WITH LEADERS FROM DIFFERENT DISCIPLINES

Latest Data, Developments & Clinical Results for IPSc, CAR-T and other novel molecules
  • Push the boundaries of cell engineering, organ replacement & iPSc based regenerative medicine
  • Understand the latest on enhanced quality & clinical results for CAR and T cell products
  • Transition technologies from bench to bedside: CRISPR, Exosomes and more…
Novel Tech Transfer, Process Development & Manufacturing Models for Commercial Success
  • Get to grips with technologies and novel platforms for efficient upstream and downstream processes
  • Simplify manufacturing automation and prepare for commercialization
  • Improve confidence in your raw material supply chain and analytical strategies
Precision Manufacturing, CDMO’s and Technology Evaluation – How & When to Innovate?
  • Build a strategy for global commercial success with forward thinking in facility design and scalability 
  • Optimise the way you work with external partners to drive commercialization
  • Prepare for successful delivery to patients & supply chain scale up

UNDERSTAND CRITICAL TRENDS ACROSS THE ENTIRE BIOPROCESSING SPECTRUM

The BioProcess International Asia 2020 covers today's best practices and lessons learned from global leaders across Asia, USA and Europe to accelerate biologics development and production.  Key topics covered at BPI Asia 2020 include:

[Workshop Day] Cell Line Development & Upstream Processing
  • Identify best practices to accelerate timelines in cell line development
  • Hear the latest on process intensification using perfusion platforms
[Workshop Day] Downstream Processing
  • Current advancements and future impact of chromatography modeling on downstream development
  • Innovations to overcome harvest and purification challenges for novel modalities
  • Proven approaches to alleviate bottlenecks created by intensified and continuous processing
Biomanufacturing Strategies & Technology Transfer
  • Build a strategy for global success with forward thinking in facility design and adopting disruptive technologies
  • Discuss scale up strategies to accelerate process development and reduce manufacturing cost
Analytical & Quality Control
  • Uncover state of the art technologies for real time process monitoring and control
  • Stay on top of advances in online cell culture process controls and their application in GMP environments
Cell Therapies & Novel Modalities
  • Gain direct feedback from Fosun Kite and Cellular Biomedicine Group on global commercialisation strategies
  • Understand economic implications of automated manufacturing and supply chain for CAR T cell therapies
Intensified & Continuous Processing
  • Strategies for the development, implementation, and regulatory approval of intensified and continuous processes
  • Implementing Continuous Processing for Novel Modalities from Small to Large Scale
  • Demonstration of fully automated, flexible and integrated continuous platform for legacy batch processes

BioProcessing

26 - 28 February, 2020

Kyoto, Japan

UNDERSTAND CRITICAL TRENDS ACROSS THE ENTIRE BIOPROCESSING SPECTRUM The BioProcess International Asia 2020 covers today's best practices and lessons learned from global leaders across Asia, USA and Europe to accelerate biologics development and production.  Key topics covered at BPI Asia 2020 include: [Workshop Day] Cell Line Development & Upstream Processing Identify best practices to accelerate timelines in cell line development Hear the latest on process intensification using perfusion platforms [Workshop Day] Downstream Processing Current advancements and future impact of chromatography modeling on downstream development Innovations to overcome harvest and purification challenges for novel modalities Proven approaches to alleviate bottlenecks created by intensified and continuous processing Biomanufacturing Strategies & Technology Transfer Build a strategy for global success with forward thinking in facility design and adopting disruptive technologies Discuss scale up strategies to accelerate process development and reduce manufacturing cost Analytical & Quality Control Uncover state of the art technologies for real time process monitoring and control Stay on top of advances in online cell culture process controls and their application in GMP environments Cell Therapies & Novel Modalities Gain direct feedback from Fosun Kite and Cellular Biomedicine Group on global commercialisation strategies Understand economic implications of automated manufacturing and supply chain for CAR T cell therapies Intensified & Continuous Processing Strategies for the development, implementation, and regulatory approval of intensified and continuous processes Implementing Continuous Processing for Novel Modalities from Small to Large Scale Demonstration of fully automated, flexible and integrated continuous platform for legacy batch processes

THE LP/VC RELATIONS EVENT

Where 350+ investors share insights and make connections

Part of the SuperReturn Series – the world's leading private equity & venture capital events

IN-DEPTH ANALYSIS ON THE LATEST POLICY AND REFORM INITIATIVES IMPACTING PRICING, QUALITY AND TRANSPARENCY

A meeting that goes beyond theory and policy to equip stakeholders with practical approaches during a time of uncertainty and the potential for seismic change.

WHAT TO EXPECT

 

Benefit from the Expertise of a Dynamic and Diverse Speaking Faculty

Kathleen Veit
Vice President, Global Compliance, Investigations & Monitoring, Teva Pharmaceuticals

Vahan Minassian
Director, U.S. Promotional Monitoring Lead, Pfizer Inc

Marie Hendrixson
Vice President, Internal Audit, Teleflex

Eren Efe
Senior Manager, Compliance Auditing & Monitoring, Becton Dickinso

Identify and Mitigate High-Priority Risk Areas
  • Speaker Programs
  • Patient Interactions
  • Publications
  • Payer communications
  • Patient Support and Assistance Programs
  • HCP Engagement
  • And more!
Discover Real-World Applications of Data Analytics and AI
Master Class A: Beginner Level — Artificial Intelligence and Anti-Fraud Data Analytics
Master Class B: Intermediate/Advanced Level — Building Up Analytics for Better Insights Across the Organization

 

UNRIVALED CONTENT AND NETWORKING TO DRIVE INNOVATIVE & COMPLIANT PROMOTIONAL PROGRAMS

The life sciences industry’s only educational forum focused on critical marketing, operations and compliance matters for sustaining best in class speaker programs. Addressing new and emerging practices for speaker program development and execution.

Find top innovation events and open innovation-related conferences on Innoget.

Innoget supports and sponsors innovation events and open innovation-related conferences all over, among many other research areas and industry sectors, for instance, photonics events, pharma events, chemistry events, corporate venturing events, hackathons, etc. List your event on Innoget and reach a global audience of 100,000+ users.

Attendance to innovation events is a great opportunity to network with like-minded professionals and experts, get to know latest developments and breakthroughts, and create unique business opportunities.

Thousands of innovation events and open innovation conferences are organised yearly worldwide. Because of the broad offer, Innoget partners with trusted innovation events organisers to provide you must-attending innovation events and open-innovation conferences. In this way, you will find here innovation events in London, innovation events in Dubai or innovation events in San Francisco, to mention just few of them. Innovation events to advance your career, project or network.

Meet experts attending at innovation events worldwide
Innoget is the most advanced innovation network to connect with decision makers attending top innovation events.

Free to join - no credit card required